NicOx SA (COX):企業のM&A・提携動向(医療分野)

◆英語タイトル:NicOx SA (COX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:GDPH62389D
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年2月17日
◆ページ数:36
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
NicOx SA (NicOx) is an pharmaceutical company that develops ophthalmic portfolio of therapies and diagnostic tools. The company’s product portfolio comprise ophthalmic products such as AdenoPlus, AzaSite, BromSite, Xailin, Vesneo, next generation NO-donors and Syk and JAK inhibitors, and others. It provides products in the therapeutic application of NO-donating compounds, based on a strong research platform which creates New Molecular Entities (NMEs). NicOx’s specialized research center in Italy works on R&D studies covering various therapy areas such as cardiovascular, inflammation and ophthalmology. The company has operations in Germany, the UK, France, Italy and the US. NicOx is headquartered in Valbonne, France.

NicOx SA (COX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
NicOx SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
NicOx SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
NicOx SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
NicOx SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
NicOx SA, Medical Devices Deals, 2011 to YTD 2017 10
NicOx SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
NicOx SA, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
NicOx Acquires Carragelose from Marinomed Biotech for USD6.9 Million 13
Venture Financing 14
Aciex Therapeutics Raises US$1.6 Million In Venture Financing 14
Aciex Therapeutics Secures US$8 Million In Venture Financing 14
Partnerships 15
Nicox Exercises Option Agreement with Bausch & Lomb to Co-Promote Latanoprostene Bunod 15
Nicox Expands Co-Marketing Agreement with Immco Diagnostics for Sjo 16
Nicox Enters into Co-Marketing Agreement with Immco Diagnostics for Sjo 16
NicOx Enters Into Co-Marketing Agreement With European Pharma Company For Eye Care Products 17
Aciex Amends Research Agreement With Portola Pharma 18
NicOx Enters Into Option Agreement With Ferrer Internacional 18
Licensing Agreements 20
Ora Enters into Licensing Agreement with Nicox Ophthalmics 20
Fera Pharma Enters into Licensing Agreement with Nicox 20
Santen Extends Licensing Agreement with Eupharmed to Distribute Cationorm 21
Akorn Enters Into Licensing Agreement With Aciex Therapeutics 22
Equity Offering 22
Nicox to Raise USD20 Million in Private Placement of Shares 22
Nicox to Raise USD29.8 Million in Private Placement of Shares 23
Asset Transactions 24
GHO Capital Partners Acquires European and International Commercial Operations of Nicox for USD29 Million 24
Acquisition 26
Valeant Pharma Acquires Nicox for USD20 Million 26
NicOx Acquires Aciex Therapeutics 27
NicOx Acquires Doliage for USD6.5 Million 28
NicOx Completes Acquisition Of Eupharmed For US$8 Million 29
NicOx Completes Acquisition Of 11.8% Stake In Altacor For US$3 Million 30
Akorn To Acquire Minority Stake In Aciex Therapeutics 31
NicOx SA – Key Competitors 33
Key Employees 34
Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
NicOx SA, Pharmaceuticals & Healthcare, Key Facts, 2015 1
NicOx SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
NicOx SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
NicOx SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
NicOx SA, Deals By Therapy Area, 2011 to YTD 2017 9
NicOx SA, Medical Devices Deals, 2011 to YTD 2017 10
NicOx SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
NicOx Acquires Carragelose from Marinomed Biotech for USD6.9 Million 13
Aciex Therapeutics Raises US$1.6 Million In Venture Financing 14
Aciex Therapeutics Secures US$8 Million In Venture Financing 14
Nicox Exercises Option Agreement with Bausch & Lomb to Co-Promote Latanoprostene Bunod 15
Nicox Expands Co-Marketing Agreement with Immco Diagnostics for Sjo 16
Nicox Enters into Co-Marketing Agreement with Immco Diagnostics for Sjo 16
NicOx Enters Into Co-Marketing Agreement With European Pharma Company For Eye Care Products 17
Aciex Amends Research Agreement With Portola Pharma 18
NicOx Enters Into Option Agreement With Ferrer Internacional 18
Ora Enters into Licensing Agreement with Nicox Ophthalmics 20
Fera Pharma Enters into Licensing Agreement with Nicox 20
Santen Extends Licensing Agreement with Eupharmed to Distribute Cationorm 21
Akorn Enters Into Licensing Agreement With Aciex Therapeutics 22
Nicox to Raise USD20 Million in Private Placement of Shares 22
Nicox to Raise USD29.8 Million in Private Placement of Shares 23
GHO Capital Partners Acquires European and International Commercial Operations of Nicox for USD29 Million 24
Valeant Pharma Acquires Nicox for USD20 Million 26
NicOx Acquires Aciex Therapeutics 27
NicOx Acquires Doliage for USD6.5 Million 28
NicOx Completes Acquisition Of Eupharmed For US$8 Million 29
NicOx Completes Acquisition Of 11.8% Stake In Altacor For US$3 Million 30
Akorn To Acquire Minority Stake In Aciex Therapeutics 31
NicOx SA, Key Competitors 33
NicOx SA, Key Employees 34
NicOx SA, Subsidiaries 35

List of Figures
NicOx SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
NicOx SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
NicOx SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
NicOx SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
NicOx SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
NicOx SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
NicOx SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
NicOx SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
NicOx SA, Medical Devices Deals, 2011 to YTD 2017 10

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ NicOx SA (COX):企業のM&A・提携動向(医療分野)(NicOx SA (COX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆